Global Echocardiography Market Size
The market for echocardiography was valued at US$1.02 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% to reach US$1.70 billion by 2030.
An echocardiogram is a test that produces moving images of the heart by using ultrasonic waves. Heart murmurs, pulmonary hypertension, congenital heart disease, heart failure, and heart infections are among the conditions for which it is used to diagnose and treat patients. An echocardiogram is also known as a heart ultrasound or an echo exam. An echocardiography can identify blood clots within the heart and fluid within the sac around the heart. Among the available echocardiograms are transthoracic, transesophageal, and stress echocardiograms. Transthoracic echocardiogram is the most common kind of echocardiography. Service providers and echocardiography laboratories are facing numerous challenges due to the COVID-19 pandemic. Healthcare professionals and public members have closely examined hospital treatment and clinics. Companies specializing in echocardiography are working harder to spread the word about the lessons learnt from past pandemics that have affected the global healthcare community, like SARS. Patients with heart illness are more likely to become infected with the novel coronavirus. To prevent jeopardizing patient care and diagnosis, businesses in the echocardiography market are stepping up their efforts to guarantee a consistent supply of echocardiogram equipment. Physicians are being trained by stakeholders and healthcare organizations to utilize point-of-care (POC) devices more frequently and to limit the time that imager devices are exposed to light.